Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
复制标题
DOI:
10.1097/fpc.0000000000000222
复制
发表时间:
2016-07
影响因子:
2.6
通讯作者:
Tyndale RF
中科院分区:
文献类型:
--
作者:
Benowitz NL;St Helen G;Dempsey DA;Jacob P 3rd;Tyndale RF
The rate of nicotine metabolism, determined primarily by CYP2A6 activity, influences tobacco dependence and smoking-induced disease risk. The prevalence of CYP2A6 gene variants differs by race, with greater numbers in African American (AA) compared to Caucasians. We studied nicotine disposition kinetics and metabolism by CYP2A6 genotype and enzymatic activity, as measured by nicotine metabolite ratio (NMR), in AA smokers. Subjects were administered IV infusions of deuterium-labeled nicotine and cotinine. Plasma and urine concentrations of nicotine and metabolites were measured, and pharmacokinetic parameters estimated. Pharmacokinetic parameters and urine metabolite excretion data were analyzed by CYP2A6 genotype and by NMR. A number of gene variants were associated with markedly reduced nicotine and cotinine clearances. NMR was strongly correlated with nicotine (r=0.72) and cotinine (r=0.80) clearances. Subjects with higher NMR excreted significantly greater nicotine C-oxidation and lower non C-oxidation products compared to lower NMR subjects. CYP2A6 genotype, NMR and nicotine pharmacokinetic data may inform studies of individual differences in smoking behavior and biomarkers of nicotine exposure.